Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP
Sign Up to like & getrecommendations! Published in 2024 at "Nature Communications"
DOI: 10.1038/s41467-024-46706-w
Abstract: Cellular entry of the hepatitis B and D viruses (HBV/HDV) requires binding of the viral surface polypeptide preS1 to the hepatobiliary transporter Na+-taurocholate co-transporting polypeptide (NTCP). This interaction can be blocked by bulevirtide (BLV, formerly… read more here.
Keywords: hbv hdv; bulevirtide; structure; hepatitis ... See more keywords